AMRX compared with TEVA: revenue, margins and what each company keeps, and the suppliers and customers both name

AMRXAmneal Pharmaceuticals, Inc.

Mkt capRevenueRevenue

TEVATeva Pharmaceutical Industries Ltd

Mkt capRevenueRevenue

Compare

AMRXAmneal Pharmaceuticals, Inc.

TEVATeva Pharmaceutical Industries Ltd

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AMRX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.6%▼−3.14%×0.20

May 8 '26±10.1%▼−3.79%×0.38

Q1 FY26±21.3%▼−1.54%×0.07

Feb 27 '26±12.6%▼−4.69%×0.37

TEVA

Reportimpliedrealized× implied

Q2 FY26—▲+9.60%—

Q1 FY26—▲+11.89%—

Jan 28 '26

= impliedAMRX realized, solidTEVA realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

—

▲+2.09%

—

Jan 12 '26—▲+2.44%—

AMRXAmneal Pharmaceuticals, Inc.

20.44▼−4.98%· post 20.44

Mkt cap$6.9BRevenue$796MQ2 FY26Revenue$3.0BFY25

TEVATeva Pharmaceutical Industries Ltd

40.77▼−3.13%· post 40.60

ClosedNov 2 '26

Mkt cap$47.4BRevenue$4.1BQ2 FY26Revenue$17.3BFY25

Compare

ClosedNov 2 '26

AMRXAmneal Pharmaceuticals, Inc.

TEVATeva Pharmaceutical Industries Ltd

20.44▼−4.98%post 20.44

Price

40.77▼−3.13%post 40.60

$6.9B

Mkt cap

$47.4B

Q2 FY26$796M

Revenue

$4.1BQ2 FY26

FY25$3.0B

Revenue

$17.3BFY25

AMRX20.44▼−4.98%vsTEVA40.77▼−3.13%ClosedNov 2 '26